title: gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
authors.affiliation: Research and Development, Bristol-Myers Squibb Company, Princeton, NJ 08543-4000, USA. robert.cherney@bms.com
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Cherney
authors.forename: Ruowei
authors.initials: R
authors.lastname: Mo
authors.forename: Dayton T
authors.initials: DT
authors.lastname: Meyer
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Voss
authors.forename: Michael G
authors.initials: MG
authors.lastname: Yang
authors.forename: Joseph B
authors.initials: JB
authors.lastname: Santella
authors.forename: John V
authors.initials: JV
authors.lastname: Duncia
authors.forename: Yvonne C
authors.initials: YC
authors.lastname: Lo
authors.forename: Gengjie
authors.initials: G
authors.lastname: Yang
authors.forename: Persymphonie B
authors.initials: PB
authors.lastname: Miller
authors.forename: Peggy A
authors.initials: PA
authors.lastname: Scherle
authors.forename: Qihong
authors.initials: Q
authors.lastname: Zhao
authors.forename: Sandhya
authors.initials: S
authors.lastname: Mandlekar
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Cvijic
authors.forename: Joel C
authors.initials: JC
authors.lastname: Barrish
authors.forename: Carl P
authors.initials: CP
authors.lastname: Decicco
authors.forename: Percy H
authors.initials: PH
authors.lastname: Carter